BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• CENTOGENE’s Lysosomal Storage Disorders Research to be Presented at the 14th Annual WORLDSymposium

  The conference, which is being held February 5-9, 2018 in San Diego, CA, presents the latest information from basic science, translational research and clinical trials for lysosomal diseases.

  February 1, 2018

   · 

  1 min read
• Sterna Biologicals to Participate in Upcoming International Conferences in H1 2018

  sterna today announces its participation in the following key scientific and partnering conferences in the first half of 2018.

  February 1, 2018

   · 

  2 min read
• Pharm Country

  Actinium Pharmaceuticals Announces Acceptance of Abstract for AACR Annual Meeting Highlighting Superior In Vivo Survival Data for Actinium Labelled Daratumumab Versus Unlabeled Daratumumab

  Actinium Pharma announced today that its abstract has been accepted for a poster presentation at the 2018 American Association for Cancer Research Annual Meeting being held April 14-18, 2018 in Chicago, Illinois.

  February 1, 2018

   · 

  7 min read
• BIOTRONIK Release: CASTLE-AF Results Published in the New England Journal of Medicine, Showing Mortality Reduction for Heart Failure Patients

  This reduction was observed when compared to patients treated with the pharmacological therapy recommended by current guidelines.

  February 1, 2018

   · 

  2 min read
• Deals

  Cardinal Health Announces Closing of Cardinal Health China Distribution Business Divestiture to Shanghai Pharma

  The sale includes Cardinal Health’s pharmaceutical and medical products distribution business in China.

  February 1, 2018

   · 

  1 min read
• Acerus Pharma’s NATESTO to Be Listed for Public Reimbursement in Quebec, Building on Strong 28% Increase in Natesto’s Canadian Prescriptions in Q4 2017

  Acerus Pharma announced that it has received notice from Quebec’s National Institute for Excellence in Health and Social Services (INESSS) of a positive recommendation to the Health Minister for the inclusion of NATESTO® on the list of medications of the Régie de l’assurance maladie du Québec.

  February 1, 2018

   · 

  5 min read
• Deals

  NH-ISAC Merges With SAFE-BioPharma Association

  NH-ISAC is pleased to announce it has merged with SAFE-BioPharma Association as of January 1, 2018.

  February 1, 2018

   · 

  3 min read
• Business

  ACT Genomics, Astra Enter Collaboration for BRCA Testing in Singapore and Taiwan

  ACT Genomics is honored to collaborate with AstraZeneca Singapore for both somatic and germline genetic testing of BRCA in patients with ovarian cancer, using the advanced next generation sequencing.

  February 1, 2018

   · 

  1 min read
• 

  Drug Development

  Investors Elated as Vertex Picks Two Top CF Triple Combos for Phase III Trials

  Vertex is keeping its promise of advancing triple combination treatments for patients with cystic fibrosis and investors are happy.

  February 1, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi

  Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi.

  February 1, 2018

   · 

  2 min read

   · 

  Mark Terry